scholarly journals Distinct changes of vascular structure and function in genetic hypertensive and metabolic syndrome rats

2005 ◽  
Vol 18 (5) ◽  
pp. A206-A206
Author(s):  
L ZHANG ◽  
L WANG ◽  
J ZHONG ◽  
T CAO ◽  
Z ZHU
Keyword(s):  
Metabolic Syndrome ◽  
Structure And Function ◽  
Vascular Structure ◽  
And Function

14.2 LONGITUDINAL CHANGE IN VASCULAR STRUCTURE AND FUNCTION OVER A 5 YEAR PERIOD IN TWINS UK COHORT

2016 ◽  
Vol 16 (C) ◽  
pp. 83
Author(s):  
Marina Cecelja ◽  
Benyu Jiang ◽  
Tim Spector ◽  
Phil Chowienczyk
Keyword(s):  
Structure And Function ◽  
Longitudinal Change ◽  
Vascular Structure ◽  
And Function

scholarly journals Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction

2012 ◽  
Vol 5 (6) ◽  
pp. 710-719 ◽  
Author(s):  
Selma F. Mohammed ◽  
Barry A. Borlaug ◽  
Véronique L. Roger ◽  
Sultan A. Mirzoyev ◽  
Richard J. Rodeheffer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Structure And Function ◽  
Vascular Structure ◽  
Preserved Ejection Fraction ◽  
And Function

scholarly journals The Association Between the Cardio-ankle Vascular Index and Other Parameters of Vascular Structure and Function in Caucasian Adults: MARK Study

2015 ◽  
Vol 22 (9) ◽  
pp. 901-911 ◽  
Author(s):  
Leticia Gomez-Sanchez ◽  
Luis Garcia-Ortiz ◽  
Maria C Patino-Alonso ◽  
José I Recio-Rodriguez ◽  
Guillermo Frontera ◽  
...  
Keyword(s):  
Structure And Function ◽  
Vascular Structure ◽  
And Function

scholarly journals Effect of wheelchair-modified rowing exercise on cardiometabolic risk factors in spinal cord injured wheelchair users: protocol for a randomised controlled trial

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e040727
Author(s):  
Rasmus Kopp Hansen ◽  
Afshin Samani ◽  
Uffe Laessoe ◽  
Aase Handberg ◽  
Ryan Godsk Larsen
Keyword(s):  
Risk Factors ◽  
Cardiometabolic Risk ◽  
Controlled Trial ◽  
Structure And Function ◽  
Cardiometabolic Risk Factors ◽  
Upper Body ◽  
Vascular Structure ◽  
Wheelchair Users ◽  
Randomised Controlled ◽  
And Function

IntroductionCardiovascular and metabolic diseases are a growing concern for individuals with spinal cord injury (SCI). Physical inactivity contributes to cardiometabolic morbidity and mortality in the SCI population. However, previous studies have shown mixed results regarding the effects of exercise on cardiometabolic risk factors in individuals with SCI. This discrepancy could be influenced by insufficient exercise stimuli. Recent guidelines recommend 30 min of moderate-to-vigorous intensity aerobic exercise, three times per week, for improvement in cardiometabolic health in individuals with SCI. However, to date, no studies have implemented an exercise intervention matching the new recommendations to examine the effects on cardiometabolic risk factors. Therefore, the primary objective of this study is to determine the effects of 12 weeks of wheelchair user-modified upper-body rowing exercise on both traditional (constituents of the metabolic syndrome) and novel (eg, vascular structure and function) cardiometabolic risk factors in manual wheelchair users with SCI.Methods and analysisA randomised controlled trial will compare 12 weeks of upper-body rowing exercise, 30 min three times per week, with a control group continuing their normal lifestyle. Outcome measurements will be performed immediately before (baseline), after 6 weeks (halfway), 12 weeks of training (post) and 6 months after the termination of the intervention period (follow-up). Outcomes will include inflammatory (eg, C reactive protein) and metabolic biomarkers determined from venous blood (with serum fasting insulin as primary outcome), body composition, arterial blood pressure, cardiorespiratory fitness level, brachial artery vascular structure and function and autonomic nervous system function.Ethics and disseminationThis trial is reported to the Danish Data Protection Agency (J.nr. 2019-899/10-0406) and approved by the Committees on Health Research Ethics in The North Denmark Region on 12 December 2019 (J.nr. N-20190053). The principal investigator will collect written informed consent from all participants prior to inclusion. Irrespective of study outcomes, the results will be submitted to peer-reviewed scientific journals for publication.Trial registration numberNCT04390087.

Sign in / Sign up

Export Citation Format

Share Document